Skip to main content
NCBI home page
Molecular and Cellular Biology logoLink to Molecular and Cellular Biology
. 1989 Feb;9(2):671–677. doi: 10.1128/mcb.9.2.671

Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation.

A Basu 1, M Raghunath 1, S Bishayee 1, M Das 1
PMCID: PMC362644  PMID: 2785240

Abstract

The tyrosine kinase activity of the epidermal growth factor (EGF) receptor is regulated by a truncated receptor of 100 kilodaltons (kDa) that contains the EGF-binding site but not the kinase domain. The inhibition of kinase is not due to competition for available EGF or for the kinase substrate-binding site. Chemical cross-linking studies suggest that the 100-kDa receptor may form a heterodimer with the intact EGF receptor. Structurally related receptor kinases, such as the platelet-derived growth factor receptor, the insulin receptor, and the Neu receptor, were not inhibited by the 100-kDa receptor. The results indicate that (i) the inhibition was specific for the EGF receptor, (ii) the kinase domain had little or no role in determining target specificity, and (iii) the regulation of kinase may be due to a specific interaction of the 100-kDa receptor with the ligand-binding domain of the EGF receptor kinase.

Full text

PDF
671

Images in this article

672Image
on p.672
673Image
on p.673
673Image
on p.673
675Image
on p.675
675Image
on p.675
676Image
on p.676

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bargmann C. I., Hung M. C., Weinberg R. A. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell. 1986 Jun 6;45(5):649–657. doi: 10.1016/0092-8674(86)90779-8. [DOI] [PubMed] [Google Scholar]
  2. Basu A., Murthy U., Rodeck U., Herlyn M., Mattes L., Das M. Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas. Cancer Res. 1987 May 15;47(10):2531–2536. [PubMed] [Google Scholar]
  3. Basu M., Biswas R., Das M. 42,000-molecular weight EGF receptor has protein kinase activity. Nature. 1984 Oct 4;311(5985):477–480. doi: 10.1038/311477a0. [DOI] [PubMed] [Google Scholar]
  4. Basu M., Frick K., Sen-Majumdar A., Scher C. D., Das M. EGF receptor-associated DNA-nicking activity is due to a Mr-100,000 dissociable protein. Nature. 1985 Aug 15;316(6029):640–641. doi: 10.1038/316640a0. [DOI] [PubMed] [Google Scholar]
  5. Basu M., Sen-Majumdar A., Basu A., Murthy U., Das M. Regulation of kinase and intermolecular bonding in intact and truncated epidermal growth factor receptor. J Biol Chem. 1986 Sep 25;261(27):12879–12882. [PubMed] [Google Scholar]
  6. Bishayee S., Majumdar S., Scher C. D., Khan S. Characterization of a novel anti-peptide antibody that recognizes a specific conformation of the platelet-derived growth factor receptor. Mol Cell Biol. 1988 Sep;8(9):3696–3702. doi: 10.1128/mcb.8.9.3696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Biswas R., Basu M., Sen-Majumdar A., Das M. Intrapeptide autophosphorylation of the epidermal growth factor receptor: regulation of kinase catalytic function by receptor dimerization. Biochemistry. 1985 Jul 2;24(14):3795–3802. doi: 10.1021/bi00335a056. [DOI] [PubMed] [Google Scholar]
  8. Böni-Schnetzler M., Pilch P. F. Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding. Proc Natl Acad Sci U S A. 1987 Nov;84(22):7832–7836. doi: 10.1073/pnas.84.22.7832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carpenter G. Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem. 1987;56:881–914. doi: 10.1146/annurev.bi.56.070187.004313. [DOI] [PubMed] [Google Scholar]
  10. Chen W. S., Lazar C. S., Poenie M., Tsien R. Y., Gill G. N., Rosenfeld M. G. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. 1987 Aug 27-Sep 2Nature. 328(6133):820–823. doi: 10.1038/328820a0. [DOI] [PubMed] [Google Scholar]
  11. Honegger A. M., Dull T. J., Felder S., Van Obberghen E., Bellot F., Szapary D., Schmidt A., Ullrich A., Schlessinger J. Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell. 1987 Oct 23;51(2):199–209. doi: 10.1016/0092-8674(87)90147-4. [DOI] [PubMed] [Google Scholar]
  12. Hunter T., Cooper J. A. Protein-tyrosine kinases. Annu Rev Biochem. 1985;54:897–930. doi: 10.1146/annurev.bi.54.070185.004341. [DOI] [PubMed] [Google Scholar]
  13. Koland J. G., Cerione R. A. Growth factor control of epidermal growth factor receptor kinase activity via an intramolecular mechanism. J Biol Chem. 1988 Feb 15;263(5):2230–2237. [PubMed] [Google Scholar]
  14. Merlino G. T., Ishii S., Whang-Peng J., Knutsen T., Xu Y. H., Clark A. J., Stratton R. H., Wilson R. K., Ma D. P., Roe B. A. Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells. Mol Cell Biol. 1985 Jul;5(7):1722–1734. doi: 10.1128/MCB.5.7.1722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Murthy U., Basu A., Rodeck U., Herlyn M., Ross A. H., Das M. Binding of an antagonistic monoclonal antibody to an intact and fragmented EGF-receptor polypeptide. Arch Biochem Biophys. 1987 Feb 1;252(2):549–560. doi: 10.1016/0003-9861(87)90062-2. [DOI] [PubMed] [Google Scholar]
  16. Murthy U., Basu M., Sen-Majumdar A., Das M. Perinuclear location and recycling of epidermal growth factor receptor kinase: immunofluorescent visualization using antibodies directed to kinase and extracellular domains. J Cell Biol. 1986 Aug;103(2):333–342. doi: 10.1083/jcb.103.2.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Northwood I. C., Davis R. J. Activation of the epidermal growth factor receptor tyrosine protein kinase in the absence of receptor oligomerization. J Biol Chem. 1988 Jun 5;263(16):7450–7453. [PubMed] [Google Scholar]
  18. Pike L. J., Gallis B., Casnellie J. E., Bornstein P., Krebs E. G. Epidermal growth factor stimulates the phosphorylation of synthetic tyrosine-containing peptides by A431 cell membranes. Proc Natl Acad Sci U S A. 1982 Mar;79(5):1443–1447. doi: 10.1073/pnas.79.5.1443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pike L. J., Kuenzel E. A., Casnellie J. E., Krebs E. G. A comparison of the insulin- and epidermal growth factor-stimulated protein kinases from human placenta. J Biol Chem. 1984 Aug 10;259(15):9913–9921. [PubMed] [Google Scholar]
  20. Schwartz R. H. Antigen presentation: fugue in T-lymphocyte recognition. Nature. 1987 Apr 23;326(6115):738–739. doi: 10.1038/326738a0. [DOI] [PubMed] [Google Scholar]
  21. Weber W., Gill G. N., Spiess J. Production of an epidermal growth factor receptor-related protein. Science. 1984 Apr 20;224(4646):294–297. doi: 10.1126/science.6324343. [DOI] [PubMed] [Google Scholar]
  22. Weiss R. A. Receptor molecule blocks HIV. Nature. 1988 Jan 7;331(6151):15–15. doi: 10.1038/331015a0. [DOI] [PubMed] [Google Scholar]
  23. Yarden Y., Schlessinger J. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry. 1987 Mar 10;26(5):1443–1451. doi: 10.1021/bi00379a035. [DOI] [PubMed] [Google Scholar]

Articles from Molecular and Cellular Biology are provided here courtesy of Taylor & Francis

RESOURCES